<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Eighteen tissue samples from lymphoproliferative lesions and <z:hpo ids='HP_0002665'>lymphomas</z:hpo> in <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> states were investigated for their content of Epstein-Barr virus (EBV) genome by dot blotting and for the distribution of EBV in tissue sections by in situ hybridization </plain></SENT>
<SENT sid="1" pm="."><plain>Fourteen <z:hpo ids='HP_0002665'>lymphomas</z:hpo> from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> patients and four children with disorders of the immune system were available </plain></SENT>
<SENT sid="2" pm="."><plain>For control reasons, six cases of <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">infectious mononucleosis</z:e> (IM) and eight Burkitt's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) from <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e>-free regions of Africa were included in the study </plain></SENT>
<SENT sid="3" pm="."><plain>Two different patterns of EBV distribution are described: 1) <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> scattered EBV-positive cells, as originally seen in IM and therefore called the IM-type pattern, 2) and a <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>-type pattern seen in endemic Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> with homogeneous EBV-positive cells <z:hpo ids='HP_0000001'>all</z:hpo> over the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>In <z:hpo ids='HP_0002665'>lymphomas</z:hpo> in patients with inborn <z:hpo ids='HP_0002721'>immunodeficiencies</z:hpo>, an IM-type pattern was found </plain></SENT>
<SENT sid="5" pm="."><plain>In <z:hpo ids='HP_0002665'>lymphomas</z:hpo> from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> patients, the two different patterns were found </plain></SENT>
<SENT sid="6" pm="."><plain>There were <z:hpo ids='HP_0002665'>lymphomas</z:hpo> with the IM-type pattern as well as some with the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>-type pattern </plain></SENT>
<SENT sid="7" pm="."><plain>In some <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>-associated <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, both patterns occurred in one <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>The findings suggest that it is not the disease process that is the distinguishing feature between the two patterns of <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> but rather the patient's underlying disease and the extent of this disease </plain></SENT>
</text></document>